Cacciarelli TV et al. |
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1999 |
Transplantation |
pmid:10507484
|
Burroughs TE et al. |
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. |
2007 |
Transplantation |
pmid:17452891
|
Vincenti F |
A decade of progress in kidney transplantation. |
2004 |
Transplantation |
pmid:15201687
|
Burke GW et al. |
Advances in pancreas transplantation. |
2004 |
Transplantation |
pmid:15201688
|
Pfitzmann R et al. |
Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. |
2003 |
Transplantation |
pmid:12865798
|
Moss MC et al. |
Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? |
2014 |
Transplantation |
pmid:24492429
|
Fridell JA et al. |
Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. |
2006 |
Transplantation |
pmid:16906038
|
Narayanan M et al. |
Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression. |
2013 |
Transplantation |
pmid:23423268
|
Moffatt SD et al. |
Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. |
1999 |
Transplantation |
pmid:10342309
|
Yoshihara S et al. |
Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. |
2004 |
Transplantation |
pmid:15077022
|
Bierer BE et al. |
Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. |
1990 |
Transplantation |
pmid:1694317
|
Yin DP et al. |
Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. |
2001 |
Transplantation |
pmid:11391223
|
Krentz AJ |
Posttransplantation Diabetes Mellitus in FK-506-Treated Renal Transplant Recipients: Analysis of Incidence and Risk Factors. Transplantation 2001; 72: 1655. |
2001 |
Transplantation |
pmid:11726815
|
Bruce DS et al. |
Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. |
2001 |
Transplantation |
pmid:11726823
|
Sanchez-Campos S et al. |
Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. |
1998 |
Transplantation |
pmid:9679826
|
Egeland EJ et al. |
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation. |
2017 |
Transplantation |
pmid:28452920
|
Hsiau M et al. |
Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. |
2011 |
Transplantation |
pmid:21857278
|
Yates CJ et al. |
Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. |
2013 |
Transplantation |
pmid:23902993
|
Kaplan B et al. |
Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage. |
1996 |
Transplantation |
pmid:8900321
|
Bronster DJ et al. |
Tacrolimus-associated mutism after orthotopic liver transplantation. |
2000 |
Transplantation |
pmid:11014653
|
Lufft V et al. |
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. |
1996 |
Transplantation |
pmid:8779695
|
Yu S et al. |
Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. |
2006 |
Transplantation |
pmid:16421475
|
Muraki T et al. |
Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood. |
1998 |
Transplantation |
pmid:9583878
|
Kadry Z et al. |
Kaposi's sarcoma in liver transplant recipients on FK506. |
1998 |
Transplantation |
pmid:9583882
|
Ho ET et al. |
Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. |
2013 |
Transplantation |
pmid:23542469
|
Shapiro R et al. |
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. |
2008 |
Transplantation |
pmid:18431232
|
Porrini E et al. |
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. |
2008 |
Transplantation |
pmid:18431233
|
Veroux M et al. |
Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications. |
2012 |
Transplantation |
pmid:22298033
|
Inoue T et al. |
Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. |
2000 |
Transplantation |
pmid:11003356
|
Holt S and Moore K |
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. |
2002 |
Transplantation |
pmid:11907407
|
Yang H et al. |
Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model. |
2002 |
Transplantation |
pmid:11907415
|
St A Nunes FA and Lucey MR |
Searching for a balance when applying immunosuppression after liver transplantation. |
2001 |
Transplantation |
pmid:11258425
|
Podesser BK et al. |
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. |
2005 |
Transplantation |
pmid:15714171
|
Steinmüller TM et al. |
The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial. |
1994 |
Transplantation |
pmid:7524203
|
Sonoda T et al. |
Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in japan. |
2003 |
Transplantation |
pmid:12548123
|
Roberti I et al. |
Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection. |
1992 |
Transplantation |
pmid:1384182
|
Guthery SL et al. |
Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. |
2003 |
Transplantation |
pmid:12698085
|
Jain A et al. |
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. |
2003 |
Transplantation |
pmid:12698091
|
Peng Y et al. |
Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. |
2013 |
Transplantation |
pmid:23263506
|
Murase N et al. |
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. |
1993 |
Transplantation |
pmid:7678353
|
Chan L et al. |
Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients. |
2010 |
Transplantation |
pmid:20517177
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
Takahashi K et al. |
Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan. |
2014 |
Transplant. Proc. |
pmid:24655975
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Park K et al. |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study. |
2000 |
Transplant. Proc. |
pmid:11119901
|
Lane BC et al. |
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679829
|
Christians U et al. |
High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721262
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Cadoff EM et al. |
Assay of FK 506 in plasma. |
1990 |
Transplant. Proc. |
pmid:1689898
|
Rahamimov R et al. |
Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol. |
2003 |
Transplant. Proc. |
pmid:12644082
|
Sgrosso JL et al. |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. |
2002 |
Transplant. Proc. |
pmid:11959214
|
Rodrigo E et al. |
High initial blood levels of tacrolimus in overweight renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15866635
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
MartÃnez-Castelao A et al. |
Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression. |
2005 |
Transplant. Proc. |
pmid:16386539
|
Sessa A et al. |
Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19460510
|
Armenta Bautista A et al. |
Renal Transplantation in Second-Level Private Hospitals in the State of Mexico. |
2018 |
Transplant. Proc. |
pmid:29579825
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Ullman KS et al. |
Site of action of cyclosporine and FK 506 in the pathways of communication between the T-lymphocyte antigen receptor and the early activation genes. |
1991 |
Transplant. Proc. |
pmid:1721294
|
Yang S et al. |
Characteristics of long-term immunosuppressive therapy in Chinese pediatric renal transplant patients: a single-center experience. |
2009 |
Transplant. Proc. |
pmid:20005361
|
Hohage H et al. |
Cyclosporine and tacrolimus: influence on cardiovascular risk factors. |
2005 |
Transplant. Proc. |
pmid:15848615
|
Nassar CA et al. |
Effects of long-term FK 506 therapy on the alveolar bone and cementum of rats. |
2009 |
Transplant. Proc. |
pmid:19545747
|
Kurnatowska I et al. |
Tacrolimus dose and blood concentration variability in kidney transplant recipients undergoing conversion from twice daily to once daily modified release tacrolimus. |
2011 |
Transplant. Proc. |
pmid:21996199
|
Moscicka M et al. |
The effect of cyclosporine and tacrolimus on indigenous bacterial flora in human skin grafts. |
2003 |
Transplant. Proc. |
pmid:14529942
|
Ricordi C et al. |
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. |
1992 |
Transplant. Proc. |
pmid:1376512
|
Kim HC et al. |
Primary immunosuppression with tacrolimus in renal transplantation: a single center experience. |
2003 |
Transplant. Proc. |
pmid:12591370
|
Cooper MH et al. |
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. |
1991 |
Transplant. Proc. |
pmid:1721326
|
Chen JW et al. |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176460
|
Costa A et al. |
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. |
1997 |
Transplant. Proc. |
pmid:9142281
|
Aktürk S et al. |
Average Tacrolimus Trough Level in the First Month After Transplantation May Predict Acute Rejection. |
2017 |
Transplant. Proc. |
pmid:28340806
|
Sakamoto K et al. |
Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. |
1995 |
Transplant. Proc. |
pmid:7533434
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721358
|
Nalesnik MA et al. |
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. |
1991 |
Transplant. Proc. |
pmid:1703335
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Busuttil RW and Holt CD |
Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123119
|
Namieno T and Uchino J |
Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells. |
1996 |
Transplant. Proc. |
pmid:8908147
|
Arita C et al. |
Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. |
1989 |
Transplant. Proc. |
pmid:2468206
|
Tze WJ et al. |
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. |
1991 |
Transplant. Proc. |
pmid:1721391
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Weinbroum AA et al. |
Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. |
2001 |
Transplant. Proc. |
pmid:11543812
|
Zuckermann A et al. |
Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083518
|
Ohdan H et al. |
Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123589
|
Maass E et al. |
Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report. |
2007 |
Transplant. Proc. |
pmid:18089410
|
Mabuchi M et al. |
Insulin-like growth factor-I enhances choleretic action of FK506 in rats. |
2003 |
Transplant. Proc. |
pmid:12826230
|
McLaughlin GE et al. |
Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. |
2000 |
Transplant. Proc. |
pmid:10812158
|
Lo A et al. |
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12742477
|
El-Sabrout R et al. |
Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176636
|
Wu M et al. |
Cyclosporine and tacrolimus alter renin-angiotesin system in mouse medullary-thick ascending limb cultured cells. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267198
|
Halloran PF et al. |
Calcineurin and the biological effect of cyclosporine and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9723430
|
Walgenbach KJ et al. |
Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506. |
1998 |
Transplant. Proc. |
pmid:9745501
|
Murio JE et al. |
Compassionate use of FK 506 in liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7544501
|
Kim YE and Eun SC |
Effect of FK506 ointment (Protopic) on rat skin allograft model. |
2014 |
Transplant. Proc. |
pmid:24815165
|
Sainsbury TS et al. |
Differential effects of FK 506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata. |
1991 |
Transplant. Proc. |
pmid:1721453
|
Shingaki S et al. |
Graft-versus-host Disease-free, Relapse-free Survival After HLA-identical Sibling Peripheral Blood Stem Cell Transplantation With Tacrolimus-based Graft-versus-host Disease Prophylaxis in Japanese Patients. |
|
Transplant. Proc. |
pmid:29407317
|
Umbro I et al. |
Long-term interleukin-2 assessment after conversion from a twice-daily to once-daily tacrolimus regimen in stable kidney recipients. |
2012 |
Transplant. Proc. |
pmid:22974867
|
Tariciotti L et al. |
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report. |
2016 |
Transplant. Proc. |
pmid:27932158
|
Miyagawa S et al. |
Mechanism of unresponsiveness in rats induced by a short course of FK 506 or CyA. |
1991 |
Transplant. Proc. |
pmid:1703687
|
Pridöhl O et al. |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750384
|